Paradigm Diagnostics Competitors and Similar CompaniesClear all
Paradigm Diagnostics's competitors and similar companies include Arch Oncology, Divide & Conquer, ARIAD Pharmaceuticals and TRON.
 Paradigm Diagnostics Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing. |  Arch Oncology Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer. |  Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. |  ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. |  TRON TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases. | |
Founding Date | Founding Date 2012 | Founding Date 2006 | Founding Date 2018 | Founding Date 1991 | Founding Date 2010 |
Type | Type Private | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Phoenix, US HQ | Locations Brisbane, US HQ St. Louis, US | Locations Babraham, GB HQ | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Mainz, DE HQ |
Employees | Employees 717% increase | Employees 7 | Employees 2 | Employees 1381% increase | Employees 1903% increase |
Funding | |||||
Latest funding round | Latest funding round $ 15m (almost 7 years ago) | Latest funding round $ 105m (about 5 years ago) | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 23.9m | Total funding raised $ 155m | Total funding raised $ 12.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Arch Oncology
HQ
Brisbane, US
Employees
7
Arch Oncology is a clinical-stage immuno-oncology company focused on the discovery and development of antibody therapies for the treatment of patients with cancer.
View companyDivide & Conquer
HQ
Babraham, GB
Employees
2
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View companyARIAD Pharmaceuticals
HQ
Cambridge, US
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View companyTRON
HQ
Mainz, DE
Employees
190↑ 3% increase
TRON Mainz is a biopharmaceutical research organization that offers diagnostics and drugs for the treatment of cancer and other severe diseases.
View company